361 related articles for article (PubMed ID: 24002203)
1. Bone mineral density loss, osteoporosis, and fractures in HIV.
Labarga P
AIDS Rev; 2013; 15(3):189-90. PubMed ID: 24002203
[TBL] [Abstract][Full Text] [Related]
2. Is there enough evidence to use bisphosphonates in HIV-infected patients? A systematic review and meta-analysis.
Pinzone MR; Moreno S; Cacopardo B; Nunnari G
AIDS Rev; 2014; 16(4):213-22. PubMed ID: 25300622
[TBL] [Abstract][Full Text] [Related]
3. Valid treatment options for osteoporosis and osteopenia in HIV-infected persons.
Clay PG; Voss LE; Williams C; Daume EC
Ann Pharmacother; 2008 May; 42(5):670-9. PubMed ID: 18413693
[TBL] [Abstract][Full Text] [Related]
4. Management of bone mineral density in HIV-infected patients.
Negredo E; Bonjoch A; Clotet B
Expert Opin Pharmacother; 2016; 17(6):845-52. PubMed ID: 26809940
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral abnormalities in persons with HIV infection: signal or noise?
Singh K; Moyle GJ
AIDS Read; 2006 Aug; 16(8):407-10, 413-8. PubMed ID: 16933375
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapeutic management of osteoprosis and osteopenia.
Alexander IM
Nurse Pract; 2009 Jun; 34(6):30-40; quiz 41. PubMed ID: 19474629
[No Abstract] [Full Text] [Related]
7. [Metabolic bone disorders in HIV patients].
Reisfeld S; Chowers M
Harefuah; 2013 Apr; 152(4):238-41, 245. PubMed ID: 23844528
[TBL] [Abstract][Full Text] [Related]
8. [Are bones in HIV-infected patient really fragile?].
Biver E; Ciaffi L; Rizzoli R; Calmy A
Rev Med Suisse; 2013 Jun; 9(390):1246-50. PubMed ID: 23821841
[TBL] [Abstract][Full Text] [Related]
9. [Alendronate].
Okazaki R
Clin Calcium; 2008 Oct; 18(10):1410-6. PubMed ID: 18830037
[TBL] [Abstract][Full Text] [Related]
10. Protecting bone in long-term HIV positive patients receiving antiretrovirals.
McGinty T; Mallon P
Expert Rev Anti Infect Ther; 2016 Jun; 14(6):587-99. PubMed ID: 27189695
[TBL] [Abstract][Full Text] [Related]
11. Skeletal morbidity in inflammatory bowel disease.
van Hogezand RA; Hamdy NA
Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
[TBL] [Abstract][Full Text] [Related]
12. Bone density in heart or lung transplant recipients--a longitudinal study.
Wang TK; O'Sullivan S; Gamble GD; Ruygrok PN
Transplant Proc; 2013; 45(6):2357-65. PubMed ID: 23747143
[TBL] [Abstract][Full Text] [Related]
13. Osteopenia in HIV infection.
Carr A
AIDS Clin Care; 2001 Aug; 13(8):71-3, 78. PubMed ID: 11547460
[No Abstract] [Full Text] [Related]
14. Bisphosphonates effective in preventing bone complications associated with androgen deprivation therapy.
J Support Oncol; 2006 Feb; 4(2):99-100. PubMed ID: 16499137
[No Abstract] [Full Text] [Related]
15. [The significance of HIV to bone mineral density].
Wessman M; Weis N; Katzenstein TL; Lebech AM; Thorsteinsson K; Hansen AE; Jensen JB
Ugeskr Laeger; 2017 Sep; 179(36):. PubMed ID: 28874254
[TBL] [Abstract][Full Text] [Related]
16. [New bone density conservation agents for osteoporosis under research and development: ED-71].
Hagino H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():454-8. PubMed ID: 18161148
[No Abstract] [Full Text] [Related]
17. Glucocorticoid-induced osteoporosis.
Berris KK; Repp AL; Kleerekoper M
Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of bone mineral density in Iranian HIV/AIDS patients.
Badie BM; Soori T; Kheirandish P; Izadyar S; SeyedAlinagh S; Foroughi M; Rostamian A; Mohraz M
Acta Med Iran; 2011; 49(7):460-7. PubMed ID: 21960080
[TBL] [Abstract][Full Text] [Related]
19. [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
Shiraki M
Nihon Rinsho; 2007 Nov; 65 Suppl 9():447-53. PubMed ID: 18161147
[No Abstract] [Full Text] [Related]
20. [Osteoporosis treatment].
Uebelhart B; Rizzoli R
Rev Med Suisse; 2006 Jan; 2(47):47-51. PubMed ID: 16465945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
